Sanofi is set to acquire DR-0201 from Dren Bio for up to $1.9 billion, aiming to expand its autoimmune disease pipeline with ...

Sanofi has won FDA approval for its sutimlimab for cold agglutinin disease (CAD) at the second time of asking, becoming the first approved therapy for the rare blood disorder in the US.

who developed COVID-19-associated cold agglutinin syndrome (CAS), a condition that resembles cold agglutinin disease (CAD) but is secondary to an underlying disorder. The report, published in the ...

and cold agglutinin disease (CAD), with slightly earlier programmes in haematopoietic stem cell transplantation-associated thrombotic microangiopathy (HSCT-TMA) and amyotrophic lateral sclerosis ...

Researchers found that ArfGAP2 appears to play a key role in both normal immune responses and harmful overactivity.

EMPAVELI's unique mechanism of targeting C3 broadens its applicability beyond PNH, including other complement-driven diseases like geographic atrophy and immune complex-mediated diseases. With ...

New findings show that the mitochondria powering our cells also control the ability of a DNA repair protein to suppress the senescence-associated secretory phenotype (SASP), which causes zombie-like ...

June 10, 2024 — Scientists have grown 'mini-guts' in the lab to help understand Crohn's disease, showing that 'switches' that modify DNA in gut cells play an ... Apr. 24, 2024 — Study ...

Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...

BRISBANE, Calif., March 17, 2025 (GLOBE NEWSWIRE) -- Annexon, Inc. (Nasdaq: ANNX), a biopharmaceutical company advancing a late-stage clinical platform of novel therapies for people living with ...